{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:19:41Z","timestamp":1780481981873,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"University of Alabama at Birmingham (UAB) Comprehensive Cancer Center","award":["P30CA013148"],"award-info":[{"award-number":["P30CA013148"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1R01CA175012"],"award-info":[{"award-number":["1R01CA175012"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01CA151538"],"award-info":[{"award-number":["R01CA151538"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajp.amjpathol.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ajpath.2015.11.003","type":"journal-article","created":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T05:53:37Z","timestamp":1453269217000},"page":"678-690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Inhibition of Transforming Growth Factor-\u03b2 Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma"],"prefix":"10.1016","volume":"186","author":[{"given":"Ailing","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel A.","family":"Pallero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixian","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Suto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne E.","family":"Murphy-Ullrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2015.11.003_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-pathol-011110-130249","article-title":"Pathogenesis of myeloma","volume":"6","author":"Anderson","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib2","doi-asserted-by":"crossref","first-page":"e9870","DOI":"10.1371\/journal.pone.0009870","article-title":"TGF-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth","volume":"5","author":"Takeuchi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2015.11.003_bib3","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1182\/blood.V87.5.1928.1928","article-title":"Transforming growth factor-beta1: differential effects on multiple myeloma versus normal B cells","volume":"87","author":"Urashima","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2015.11.003_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1089\/jir.2007.0009","article-title":"Transforming growth factor-beta signaling in normal and malignant hematopoiesis","volume":"27","author":"Isufi","year":"2007","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.ajpath.2015.11.003_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bone.2010.05.036","article-title":"TGF-beta-related mechanisms of bone destruction in multiple myeloma","volume":"48","author":"Matsumoto","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.ajpath.2015.11.003_bib6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-2141.2004.04984.x","article-title":"Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma","volume":"125","author":"Brown","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib7","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1158\/1078-0432.CCR-04-0632","article-title":"Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment","volume":"10","author":"Hayashi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2015.11.003_bib8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/ijc.29078","article-title":"Dynamic balance of multiple myeloma clonogenic side population cell percentages controlled by environmental conditions","volume":"136","author":"Wen","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2015.11.003_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jcp.1041600214","article-title":"TGF beta alters growth and differentiation related gene expression in proliferating osteoblasts in\u00a0vitro, preventing development of the mature bone phenotype","volume":"160","author":"Breen","year":"1994","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib10","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1210\/en.2009-0813","article-title":"Transforming growth factor-{beta} coordinately induces suppressor of cytokine signaling 3 and leukemia inhibitory factor to suppress osteoclast apoptosis","volume":"151","author":"Ruan","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajpath.2015.11.003_bib11","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/j.yexcr.2008.06.006","article-title":"TGF-beta coordinately activates TAK1\/MEK\/AKT\/NFkB and SMAD pathways to promote osteoclast survival","volume":"314","author":"Gingery","year":"2008","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ajpath.2015.11.003_bib12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/leu.2013.254","article-title":"Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in\u00a0vitro and in\u00a0vivo studies","volume":"28","author":"Frassanito","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.ajpath.2015.11.003_bib13","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood-2011-04-347484","article-title":"Multiple myeloma-related deregulation of bone marrow-derived CD34+ hematopoietic stem and progenitor cells","volume":"120","author":"Bruns","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2015.11.003_bib14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGFbeta","volume":"10","author":"Flavell","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1242\/jcs.00229","article-title":"Making sense of latent TGFbeta activation","volume":"116","author":"Annes","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ajpath.2015.11.003_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ejcb.2008.01.012","article-title":"Integrins and the activation of latent transforming growth factor beta1: an intimate relationship","volume":"87","author":"Wipff","year":"2008","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1359-6101(99)00029-5","article-title":"Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology","volume":"11","author":"Murphy-Ullrich","year":"2000","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ajpath.2015.11.003_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.matbio.2012.01.006","article-title":"Thrombospondin1 in tissue repair and fibrosis: TGF-beta-dependent and independent mechanisms","volume":"31","author":"Sweetwyne","year":"2012","journal-title":"Matrix Biol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2014.07.005","article-title":"Revisiting the matricellular concept","volume":"37","author":"Murphy-Ullrich","year":"2014","journal-title":"Matrix Biol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.matbio.2014.02.001","article-title":"Invoking the power of thrombospondins: regulation of thrombospondins expression","volume":"37","author":"Stenina-Adognravi","year":"2014","journal-title":"Matrix Biol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.matbio.2014.01.002","article-title":"Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease","volume":"37","author":"Rogers","year":"2014","journal-title":"Matrix Biol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-0609.2009.01396.x","article-title":"Treatment response to bortezomib in multiple myeloma correlates with plasma hepatocyte growth factor concentration and bone marrow thrombospondin concentration","volume":"84","author":"Ludek","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib23","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1365-2141.2007.06729.x","article-title":"Dysregulation of CD47 and the ligands thrombospondin 1 and 2 in multiple myeloma","volume":"138","author":"Rendtlew Danielsen","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib24","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood-2009-03-211920","article-title":"Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease","volume":"114","author":"Kukreja","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2015.11.003_bib25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.matbio.2012.01.002","article-title":"Thrombospondins in physiology and disease: new tricks for old dogs","volume":"31","author":"Murphy-Ullrich","year":"2012","journal-title":"Matrix Biol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib26","doi-asserted-by":"crossref","first-page":"13586","DOI":"10.1074\/jbc.274.19.13586","article-title":"The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta","volume":"274","author":"Ribeiro","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2015.11.003_bib27","doi-asserted-by":"crossref","first-page":"38032","DOI":"10.1074\/jbc.M405658200","article-title":"Molecular interactions that confer latency to transforming growth factor-beta","volume":"279","author":"Young","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2015.11.003_bib28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9440(10)63319-6","article-title":"Expression of the type-1 repeats of thrombospondin-1 inhibits tumor growth through activation of transforming growth factor-beta","volume":"165","author":"Yee","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib29","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0092-8674(00)81460-9","article-title":"Thrombospondin-1 is a major activator of TGF-beta1 in\u00a0vivo","volume":"93","author":"Crawford","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2015.11.003_bib30","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2353\/ajpath.2007.070056","article-title":"A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II","volume":"171","author":"Belmadani","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib31","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.ajpath.2011.02.039","article-title":"Blockade of TSP1-dependent TGF-beta activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy","volume":"178","author":"Lu","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/jcp.20735","article-title":"Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization","volume":"209","author":"Ueno","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib33","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.bbrc.2012.05.020","article-title":"Thrombospondin-1 inhibits osteogenic differentiation of human mesenchymal stem cells through latent TGF-beta activation","volume":"422","author":"Bailey Dubose","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2015.11.003_bib34","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/blood.V96.7.2528","article-title":"Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins","volume":"96","author":"Borset","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2015.11.003_bib35","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1182\/blood-2004-06-2141","article-title":"Heparanase promotes the spontaneous metastasis of myeloma cells to bone","volume":"105","author":"Yang","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2015.11.003_bib36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood-2002-12-3905","article-title":"Dual effects of macrophage inflammatory protein-1alpha on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease","volume":"102","author":"Oyajobi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2015.11.003_bib37","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1083\/jcb.122.4.923","article-title":"Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism (published correction appears in J Cell Biol 1993;122[5]:following 1143)","volume":"122","author":"Schultz-Cherry","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1538-7836.2006.01723.x","article-title":"Function-blocking antithrombospondin-1 monoclonal antibodies","volume":"4","author":"Annis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajpath.2015.11.003_bib39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S8756-3282(97)00056-2","article-title":"A murine model of human myeloma bone disease","volume":"20","author":"Garrett","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.ajpath.2015.11.003_bib40","first-page":"8749","article-title":"High heparanase activity in multiple myeloma is associated with elevated microvessel density","volume":"63","author":"Kelly","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2015.11.003_bib41","doi-asserted-by":"crossref","first-page":"30377","DOI":"10.1074\/jbc.M111.254789","article-title":"Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype","volume":"286","author":"Purushothaman","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2015.11.003_bib42","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1158\/0008-5472.CAN-10-2179","article-title":"Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2015.11.003_bib43","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1038\/bjc.2012.460","article-title":"Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in\u00a0vitro and ex\u00a0vivo","volume":"107","author":"Weiss","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2015.11.003_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/8756-3282(92)90012-L","article-title":"Modulation of thrombospondin gene expression during osteoblast differentiation in MC3T3-E1 cells","volume":"13","author":"Sherbina","year":"1992","journal-title":"Bone"},{"key":"10.1016\/j.ajpath.2015.11.003_bib45","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.bone.2005.11.017","article-title":"Matricellular proteins: extracellular modulators of bone development, remodeling, and regeneration","volume":"38","author":"Alford","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.ajpath.2015.11.003_bib46","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1006\/bbrc.2000.2574","article-title":"A CD36-binding peptide from thrombospondin-1 can stimulate resorption by osteoclasts in\u00a0vitro","volume":"270","author":"Carron","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2015.11.003_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jbmr.2308","article-title":"Thrombospondin-1 regulates bone homeostasis through effects on bone matrix integrity and nitric oxide signaling in osteoclasts","volume":"30","author":"Amend","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2015.11.003_bib48","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0002-9440(10)65183-8","article-title":"Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36","volume":"155","author":"Yehualaeshet","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2015.11.003_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/bbrc.2001.4922","article-title":"Tamoxifen and estrogen effects on TGF-beta formation: role of thrombospondin-1, alphavbeta3, and integrin-associated protein","volume":"284","author":"Harpel","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2015.11.003_bib50","first-page":"25","article-title":"Actions and interactions of glucocorticoids and transforming growth factor beta on two related human myeloma cell lines","volume":"4","author":"Johnson","year":"1993","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.ajpath.2015.11.003_bib51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/thoraxjnl-2011-200717","article-title":"Proteasomal inhibition after injury prevents fibrosis by modulating TGF-beta(1) signalling","volume":"67","author":"Mutlu","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.ajpath.2015.11.003_bib52","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1158\/0008-5472.CAN-12-3141","article-title":"Production of gastrointestinal tumors in mice by modulating latent TGF-beta1 activation","volume":"73","author":"Shibahara","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2015.11.003_bib53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00774-008-0012-z","article-title":"Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-1alpha and MIP-1beta production","volume":"27","author":"Abe","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.ajpath.2015.11.003_bib54","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ctrv.2012.03.004","article-title":"Therapeutic approaches to myeloma bone disease: an evolving story","volume":"38","author":"Longo","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ajpath.2015.11.003_bib55","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1158\/0008-5472.CAN-10-2941","article-title":"Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TbetaRI\/II kinase inhibition with LY2109761","volume":"71","author":"Connolly","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2015.11.003_bib56","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/labinvest.3700669","article-title":"Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations","volume":"87","author":"Prud'homme","year":"2007","journal-title":"Lab Invest"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944015006537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944015006537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T23:47:50Z","timestamp":1617234470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944015006537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0002944015006537"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2015.11.003","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Transforming Growth Factor-\u03b2 Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2015.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}